Kyle Malady - 10 Apr 2025 Form 4 Insider Report for VERIZON COMMUNICATIONS INC (VZ)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
11 Apr 2025, 15:42:53 UTC
Prior SEC filing
28 Mar 2025
Next SEC filing
24 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Evgeniya Berezkina, Attorney-in-fact for Kyle Malady

Key filing fact

Kyle Malady filed Form 4 for VERIZON COMMUNICATIONS INC (VZ) on 11 Apr 2025.

Key facts

  • This page summarizes Kyle Malady's Form 4 filing for VERIZON COMMUNICATIONS INC (VZ).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 11 Apr 2025, 15:42.

Change

  • Previous filing in this sequence was filed on 28 Mar 2025.
  • Current net transaction value: +$1,731.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VZ transaction Derivative

Phantom Stock (unitized)

Award

Transaction value
$1,731
Shares
+141
Change %
+0.04%
Price
$12.25
Shares after
375,351
Date
10 Apr 2025
Ownership
By Deferred Compensation Plan
Underlying class
Common Stock
Underlying amount
40
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each share of phantom stock is the economic equivalent of a portion of one share of common stock and is settled in cash. The shares of phantom stock become payable upon events established by the reporting person in accordance with the deferred compensation plan.

Footnote F2

Includes phantom stock acquired through dividend reinvestment.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .